⌘K

Home/Filings/4/0000950170-23-023939

4//SEC Filing

AHMED NADIM 4

Accession 0000950170-23-023939

CIK 0001789972other

View on SEC.gov Company Profile

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:36 PM ET

Size

4.7 KB

Accession

0000950170-23-023939

Insider Transaction Report

Form 4

Period: 2023-05-23

Cullinan Oncology, Inc.CGEM

DirectorPresident and CEO

Transactions

Sale
Common Stock
2023-05-23$9.15/sh−707$6,469→ 116,581 total

Footnotes (1)

[F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001731193

Filing Metadata

Form type: 4
Filed: May 23, 8:00 PM ET
Accepted: May 24, 4:36 PM ET
Size: 4.7 KB

View on SEC.gov